WATCHMAN FLX™ Boston Scientific

WATCHMAN FLX is now FDA APPROVED for use in nonvalvular atrial fibrillation patients who are eligible for anticoagulation therapy. Built on the most studied and implanted LAAC device in the world, WATCHMAN FLX is designed to advance procedural performance and safety while expanding the treatable patient population. Protection against stroke. Protection against bleeds. WATCHMAN is the one-time, minimally invasive procedure that protects your non-valvular AFib (NVAF) patients for life.